DBH converts dopamine → NE using copper and vitamin C. Locus coeruleus is the CNS source; sympathetic postganglionic neurons and adrenal medulla release peripherally.
Symptom connections · 31
Connections describe mechanisms, not proof that a molecule causes a symptom. Tissue, regulation and clinical context matter.
PCOS (PMOS)Indirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
Adipose IL-6/TNF worsens IR and ovarian dysfunction.
Hashimoto'sIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
Cytokines suppress deiodinases.
Thyroid dysfunctionIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Cortisol: Sympathetic + HPA co-activate under threat. · established
High cortisol suppresses TSH and D1.
EndometriosisIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
Peritoneal cytokine milieu is highly inflamed.
DepressionIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
IL-6/TNF drive sickness behaviour.
Brain fogIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
Cytokines cross BBB and slow cognition.
InsomniaIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Cortisol: Sympathetic + HPA co-activate under threat. · established
Elevated late-day cortisol blocks sleep onset.
ADHDDirect curated contributor · established
LC-NE sets signal-to-noise for salience.
Brain injury / TBI recoveryIndirect connection · emerging
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Cortisol: Sympathetic + HPA co-activate under threat. · established
Cortisol → Kynurenine pathway: Cortisol induces hepatic TDO. · established
Post-TBI QA elevation is excitotoxic.
AnxietyDirect curated contributor · established
LC-NE hyperarousal.
Mast cell activationIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
Priming environment for MC hyperactivity.
LipedemaIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
Adipose inflammation is central.
Chronic fatigueIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Cortisol: Sympathetic + HPA co-activate under threat. · established
Blunted CAR predicts fatigue.
Long COVIDIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
Persistent low-grade inflammation.
POTS / dysautonomiaDirect curated contributor · established
Hyperadrenergic subtype.
HypertensionDirect curated contributor · established
Sympathetic tone raises cardiac output and vasoconstriction.
Cardiovascular diseaseIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
IL-6/TNF sustain plaque progression.
DementiaIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
Microglial activation drives synaptic loss.
Bipolar disorderIndirect connection · emerging
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
Cytokines correlate with mood episodes.
PTSDDirect curated contributor · established
Hyper-noradrenergic reactivity.
Cushing syndromeIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Cortisol: Sympathetic + HPA co-activate under threat. · established
Sustained hypercortisolism is the causal engine.
Addison's diseaseIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Cortisol: Sympathetic + HPA co-activate under threat. · established
Absolute deficiency drives fatigue, hypotension.
DysmenorrheaIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
PGF2α drives cramping.
Female infertilityIndirect connection · emerging
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
Endometrial receptivity requires low background inflammation.
Pre-eclampsiaIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
sFlt-1 / PlGF imbalance.
Metabolic syndromeIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
Adipose IL-6/TNF worsens IR.
Type 2 diabetesIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
Adipose cytokines worsen IR.
ObesityIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
Adipose inflammation is both cause and consequence.
Systemic lupus erythematosusIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
Cytokine storms during flares.
Multiple sclerosisIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
Systemic + CNS cytokines.
Atopic dermatitisIndirect connection · established
Norepinephrine → Threat (sympathetic): LC-NE drives arousal and sympathetic activation. · established
Threat (sympathetic) → Chronic inflammation: Sympathetic priming shifts cytokine tone upward. · established
IL-4/IL-13 axis is the therapeutic target.